Key result
Valve surgery denial affects ~45% of elderly mitral regurgitation patients, linked to age and impaired LVEF.
Observational (n=1,061)
Nearly half of elderly Chinese inpatients with mitral regurgitation are denied valve surgery, driven primarily by older age, comorbidities, and high surgical risk scores.
May indicate undertreatment risks in elderly Chinese MR patients; leaves open whether targeted referral strategies improve access.
OBJECTIVE: To summarize clinical characteristics and treatment strategy of Chinese elderly mitral regurgitation (MR) inpatients under the current guidelines, and to identify factors related to treatment options in them. METHODS: = 1061). The elderly group was categorized into two subgroups based on surgical status. Age, left ventricular ejection fraction (LVEF), regurgitation grade, EuroScore-II high risk stratification and having diabetes were identified as factors associated with therapy decisions in elderly MR patients. CONCLUSIONS: Valve surgery was denied in 45.29% of elderly MR inpatients. Older age, impaired LVEF, lower regurgitation grade, EuroScore-II high risk stratification, and having diabetes were factors most significantly associated with surgery denial among elderly Chinese inpatients with MR.
No takes yet. Share an insight, caveat, or question.
Zhuge et al. (2018) conducted an observational in Mitral regurgitation (n=1,061). Valve surgery vs. Surgery denial was evaluated on Surgery denial (p=< 0.05). Valve surgery was denied in 45.29% of elderly Chinese inpatients with mitral regurgitation, with older age, impaired LVEF, lower regurgitation grade, high EuroScore-II, and diabetes as key factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: